The Orphan Drug Act Turns Twenty
This article was originally published in Start Up
Executive Summary
The Orphan Drug Act was passed twenty years ago to promote research into rare disorders. The legislation has succeeded at that; companies have collected a mixed bag of wins, losses, and modest advantages.